Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) CEO Kevin Charles Gorman sold 2,707 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $140.69, for a total value of $380,847.83. Following the transaction, the chief executive officer now owns 502,188 shares of the […]
Neurocrine Biosciences, Inc (NASDAQ:NBIX) Forecasted to Post Q4 2023 Earnings of $1 17 Per Share themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Hussman Strategic Advisors Inc. lessened its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 22.0% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 28,400 shares of the company’s stock after selling 8,000 shares during the quarter. Hussman Strategic Advisors Inc.’s holdings […]
Barclays Boosts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences (NASDAQ:NBIX) Reaches New 52-Week High on Analyst Upgrade theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.